Rush Medical College, Chicago, Illinois, USA.
JACC Cardiovasc Interv. 2009 Feb;2(2):136-43. doi: 10.1016/j.jcin.2008.09.012.
This study applied risk adjustment methods to evaluate member institutions of the American College of Cardiology-National Cardiovascular Data Registry with respect to in-hospital mortality in percutaneous coronary intervention patients over a 4-year period to assess variability in risk-adjusted performance measures.
Cardiac catheterization laboratories, hospital networks, and third-party payers are interested in assessing the outcomes of percutaneous coronary interventions. Evaluation of outcomes without considering case selection may lead to erroneous conclusions about program quality.
The National Cardiovascular Data Registry database was queried for all percutaneous coronary intervention cases performed between January 1, 2001, and September 30, 2004. Random effects logistic regression was used to develop models of in-hospital mortality and compute an expected mortality rate for each program. The observed mortality rate in each program was divided by the program's predicted rate to obtain the observed/expected (O/E) mortality ratio. Change in the O/E ratio was assessed by a generalized estimating equation approach to repeated measures. An index of variability was calculated by the mean absolute difference between O/E ratios of each pair of years.
There were 664,909 interventional procedures performed in 403 National Cardiovascular Data Registry programs from 2001 to 2004. There was no significant systematic change in O/E ratios over the 4-year period, but there was significantly greater variation in O/E ratios associated with lower percutaneous coronary intervention volume programs.
Our risk-adjustment models had very good discrimination and were relatively consistent over the study period. There was substantial within-program variation in O/E ratios. This information would provide an indication for a detailed examination of individual programs.
本研究应用风险调整方法,评估美国心脏病学会-国家心血管数据注册中心(ACC-NCDR)的成员机构在 4 年期间经皮冠状动脉介入治疗(PCI)患者的院内死亡率,以评估风险调整后绩效指标的变异性。
心脏导管实验室、医院网络和第三方付款人都有兴趣评估 PCI 的结果。如果不考虑病例选择来评估结果,可能会导致对项目质量的错误结论。
在 2001 年 1 月 1 日至 2004 年 9 月 30 日期间,从国家心血管数据注册中心数据库中查询所有 PCI 病例。采用随机效应逻辑回归方法建立院内死亡率模型,并计算每个项目的预期死亡率。每个项目的实际死亡率除以项目的预测死亡率,以获得观察/预期(O/E)死亡率比值。采用广义估计方程(GEE)方法评估重复测量的 O/E 比值变化。通过计算每对年份 O/E 比值的平均绝对差来计算变异性指数。
2001 年至 2004 年,在 403 个国家心血管数据注册中心的项目中进行了 664909 例介入手术。在 4 年期间,O/E 比值没有明显的系统变化,但与 PCI 量较低的项目相比,O/E 比值的变异性显著更大。
我们的风险调整模型具有很好的区分度,并且在研究期间相对稳定。O/E 比值在项目内存在很大的差异。这些信息将为对个别项目进行详细检查提供依据。